Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.

MLA

Cook, M. N., et al. “Initial Monotherapy with Either Metformin or Sulphonylureas Often Fails to Achieve or Maintain Current Glycaemic Goals in Patients with Type 2 Diabetes in UK Primary Care.” Diabetic Medicine, vol. 24, no. 4, Apr. 2007, pp. 350–58. EBSCOhost, https://doi.org/10.1111/j.1464-5491.2007.02078.x.

APA

Cook, M. N., Girman, C. J., Stein, P. P., & Alexander, C. M. (2007). Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care. Diabetic Medicine, 24(4), 350–358. https://doi.org/10.1111/j.1464-5491.2007.02078.x

Chicago

Cook, M. N., C. J. Girman, P. P. Stein, and C. M. Alexander. 2007. “Initial Monotherapy with Either Metformin or Sulphonylureas Often Fails to Achieve or Maintain Current Glycaemic Goals in Patients with Type 2 Diabetes in UK Primary Care.” Diabetic Medicine 24 (4): 350–58. doi:10.1111/j.1464-5491.2007.02078.x.